anti ephrinb3 Search Results


91
R&D Systems anti human ephrinb3
Expression of EphB3 protein in the injured adult optic nerve and macrophages. A, Immunoblots of protein preparations from uninjured (UI) and injured adult optic nerves 8 d after injury (8) probed using an anti-EphB3 antibody. A signal at ∼110 kDa corresponding to the expected size for EphB3 protein was detected in both samples. This protein band was not present in optic nerve tissue obtained from EphB3 null animals (KO). GAPDH-immunopositive bands used as protein loading controls are shown below. B, ED1-positive macrophages isolated from segments of injured adult optic nerve in culture. C, The macrophages shown in B bound exogenously applied <t>EphrinB3-Fc</t> protein resulting in a punctate–aggregate pattern of cell-surface labeling. D, ED1-positive macrophages from segments of injured adult optic nerve in culture derived from an EphB3 homozygous null animal. E, Exogenously applied EphrinB3-Fc protein failed to bind to the EphB3 null macrophages shown in D. F, ED1-positive macrophages in an adult optic nerve 5 d after injury (green). G, EphrinB3-Fc binding in the same region shown in D (red). H, Colocalization of ED1 immunoreactivity with EphrinB3-Fc binding. Scale bars: (in B) B–E, 20 μm; (in F) F–H, 10 μm.
Anti Human Ephrinb3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human ephrinb3/product/R&D Systems
Average 91 stars, based on 1 article reviews
anti human ephrinb3 - by Bioz Stars, 2026-06
91/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology anti ephrinb3
Expression of EphB3 protein in the injured adult optic nerve and macrophages. A, Immunoblots of protein preparations from uninjured (UI) and injured adult optic nerves 8 d after injury (8) probed using an anti-EphB3 antibody. A signal at ∼110 kDa corresponding to the expected size for EphB3 protein was detected in both samples. This protein band was not present in optic nerve tissue obtained from EphB3 null animals (KO). GAPDH-immunopositive bands used as protein loading controls are shown below. B, ED1-positive macrophages isolated from segments of injured adult optic nerve in culture. C, The macrophages shown in B bound exogenously applied <t>EphrinB3-Fc</t> protein resulting in a punctate–aggregate pattern of cell-surface labeling. D, ED1-positive macrophages from segments of injured adult optic nerve in culture derived from an EphB3 homozygous null animal. E, Exogenously applied EphrinB3-Fc protein failed to bind to the EphB3 null macrophages shown in D. F, ED1-positive macrophages in an adult optic nerve 5 d after injury (green). G, EphrinB3-Fc binding in the same region shown in D (red). H, Colocalization of ED1 immunoreactivity with EphrinB3-Fc binding. Scale bars: (in B) B–E, 20 μm; (in F) F–H, 10 μm.
Anti Ephrinb3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti ephrinb3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
anti ephrinb3 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

99
R&D Systems mouse ephrin b1 extracellular domain
Expression of EphB3 protein in the injured adult optic nerve and macrophages. A, Immunoblots of protein preparations from uninjured (UI) and injured adult optic nerves 8 d after injury (8) probed using an anti-EphB3 antibody. A signal at ∼110 kDa corresponding to the expected size for EphB3 protein was detected in both samples. This protein band was not present in optic nerve tissue obtained from EphB3 null animals (KO). GAPDH-immunopositive bands used as protein loading controls are shown below. B, ED1-positive macrophages isolated from segments of injured adult optic nerve in culture. C, The macrophages shown in B bound exogenously applied <t>EphrinB3-Fc</t> protein resulting in a punctate–aggregate pattern of cell-surface labeling. D, ED1-positive macrophages from segments of injured adult optic nerve in culture derived from an EphB3 homozygous null animal. E, Exogenously applied EphrinB3-Fc protein failed to bind to the EphB3 null macrophages shown in D. F, ED1-positive macrophages in an adult optic nerve 5 d after injury (green). G, EphrinB3-Fc binding in the same region shown in D (red). H, Colocalization of ED1 immunoreactivity with EphrinB3-Fc binding. Scale bars: (in B) B–E, 20 μm; (in F) F–H, 10 μm.
Mouse Ephrin B1 Extracellular Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse ephrin b1 extracellular domain/product/R&D Systems
Average 99 stars, based on 1 article reviews
mouse ephrin b1 extracellular domain - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


Expression of EphB3 protein in the injured adult optic nerve and macrophages. A, Immunoblots of protein preparations from uninjured (UI) and injured adult optic nerves 8 d after injury (8) probed using an anti-EphB3 antibody. A signal at ∼110 kDa corresponding to the expected size for EphB3 protein was detected in both samples. This protein band was not present in optic nerve tissue obtained from EphB3 null animals (KO). GAPDH-immunopositive bands used as protein loading controls are shown below. B, ED1-positive macrophages isolated from segments of injured adult optic nerve in culture. C, The macrophages shown in B bound exogenously applied EphrinB3-Fc protein resulting in a punctate–aggregate pattern of cell-surface labeling. D, ED1-positive macrophages from segments of injured adult optic nerve in culture derived from an EphB3 homozygous null animal. E, Exogenously applied EphrinB3-Fc protein failed to bind to the EphB3 null macrophages shown in D. F, ED1-positive macrophages in an adult optic nerve 5 d after injury (green). G, EphrinB3-Fc binding in the same region shown in D (red). H, Colocalization of ED1 immunoreactivity with EphrinB3-Fc binding. Scale bars: (in B) B–E, 20 μm; (in F) F–H, 10 μm.

Journal: The Journal of Neuroscience

Article Title: EphB3: An Endogenous Mediator of Adult Axonal Plasticity and Regrowth after CNS Injury

doi: 10.1523/JNEUROSCI.4797-05.2006

Figure Lengend Snippet: Expression of EphB3 protein in the injured adult optic nerve and macrophages. A, Immunoblots of protein preparations from uninjured (UI) and injured adult optic nerves 8 d after injury (8) probed using an anti-EphB3 antibody. A signal at ∼110 kDa corresponding to the expected size for EphB3 protein was detected in both samples. This protein band was not present in optic nerve tissue obtained from EphB3 null animals (KO). GAPDH-immunopositive bands used as protein loading controls are shown below. B, ED1-positive macrophages isolated from segments of injured adult optic nerve in culture. C, The macrophages shown in B bound exogenously applied EphrinB3-Fc protein resulting in a punctate–aggregate pattern of cell-surface labeling. D, ED1-positive macrophages from segments of injured adult optic nerve in culture derived from an EphB3 homozygous null animal. E, Exogenously applied EphrinB3-Fc protein failed to bind to the EphB3 null macrophages shown in D. F, ED1-positive macrophages in an adult optic nerve 5 d after injury (green). G, EphrinB3-Fc binding in the same region shown in D (red). H, Colocalization of ED1 immunoreactivity with EphrinB3-Fc binding. Scale bars: (in B) B–E, 20 μm; (in F) F–H, 10 μm.

Article Snippet: After transfer to nitrocellulose, blots were blocked with PBS/5% anti-donkey serum or dry milk and probed with anti-mouse EphB3 (1:1000; R & D Systems) or anti-human EphrinB3 (1:500; R & D Systems).

Techniques: Expressing, Western Blot, Isolation, Labeling, Derivative Assay, Binding Assay

EphrinB3 mRNA and protein expression in the adult retina and on RGC axons. A, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer of the retina from a normal adult mouse. [See D for location of ganglion cell layer (GCL) and inner nuclear layer (INL).] B, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer 4 d after optic nerve injury. C, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer 12 d after optic nerve injury. D, Retinal section from a normal adult mouse exposed to the EphrinB3 sense control probe. E, EphrinB3 mRNA expression in the optic nerve of a normal adult mouse. A faint hybridization signal is detected in cells distributed in a row-like manner. F, EphrinB3 mRNA expression in the optic nerve of an adult mouse 4 d after optic nerve injury. G, EphrinB3 mRNA expression in the optic nerve of an adult mouse 12 d after optic nerve injury. H, Anti-EphrinB3 immunoblot. A faint signal is detected in the protein sample from uninjured optic nerves (UI). A band at ∼65 kDa, the expected size of EphrinB3, is present in the optic nerve samples 8 d after injury (8). I, Uninjured optic nerve section after staining using anti-EphrinB3 antibody. There is diffuse staining particularly at the ONH region. J, Optic nerve (ON) tissue section 12 d after injury stained with anti-EphrinB3 antibody. A strong signal was detected in the optic nerve proximal to the injury site. CT, Connective tissue; L, lesion site. K, Section from the same optic nerve shown in J after staining with a secondary antibody alone. L, Recombinant EphB3-Fc protein injected into the adult optic nerve binds to RGC axons. EphB3-Fc was detected using an anti-Fc antibody. M, Fc control protein injected into the adult optic nerve is distributed as diffuse punctate aggregates and does not result in apparent RGC axon binding. Scale bars: A–G, I–K, 100 μm; L, M, 20 μm.

Journal: The Journal of Neuroscience

Article Title: EphB3: An Endogenous Mediator of Adult Axonal Plasticity and Regrowth after CNS Injury

doi: 10.1523/JNEUROSCI.4797-05.2006

Figure Lengend Snippet: EphrinB3 mRNA and protein expression in the adult retina and on RGC axons. A, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer of the retina from a normal adult mouse. [See D for location of ganglion cell layer (GCL) and inner nuclear layer (INL).] B, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer 4 d after optic nerve injury. C, EphrinB3 mRNA expression in the ganglion cell layer and the inner nuclear layer 12 d after optic nerve injury. D, Retinal section from a normal adult mouse exposed to the EphrinB3 sense control probe. E, EphrinB3 mRNA expression in the optic nerve of a normal adult mouse. A faint hybridization signal is detected in cells distributed in a row-like manner. F, EphrinB3 mRNA expression in the optic nerve of an adult mouse 4 d after optic nerve injury. G, EphrinB3 mRNA expression in the optic nerve of an adult mouse 12 d after optic nerve injury. H, Anti-EphrinB3 immunoblot. A faint signal is detected in the protein sample from uninjured optic nerves (UI). A band at ∼65 kDa, the expected size of EphrinB3, is present in the optic nerve samples 8 d after injury (8). I, Uninjured optic nerve section after staining using anti-EphrinB3 antibody. There is diffuse staining particularly at the ONH region. J, Optic nerve (ON) tissue section 12 d after injury stained with anti-EphrinB3 antibody. A strong signal was detected in the optic nerve proximal to the injury site. CT, Connective tissue; L, lesion site. K, Section from the same optic nerve shown in J after staining with a secondary antibody alone. L, Recombinant EphB3-Fc protein injected into the adult optic nerve binds to RGC axons. EphB3-Fc was detected using an anti-Fc antibody. M, Fc control protein injected into the adult optic nerve is distributed as diffuse punctate aggregates and does not result in apparent RGC axon binding. Scale bars: A–G, I–K, 100 μm; L, M, 20 μm.

Article Snippet: After transfer to nitrocellulose, blots were blocked with PBS/5% anti-donkey serum or dry milk and probed with anti-mouse EphB3 (1:1000; R & D Systems) or anti-human EphrinB3 (1:500; R & D Systems).

Techniques: Expressing, Control, Hybridization, Western Blot, Staining, Recombinant, Injection, Binding Assay

EphB3-Fc protein supports adult RGC axon outgrowth. A, Adult retinal explant grown on a substratum coated with low levels of laminin (2.5 μg/ml). This level of laminin coating supports only minimal axon outgrowth (arrow points to an axon). B, Adult retinal explant grown for 3 d on a substratum coated with low laminin (2.5 μg/ml) and EphB3-Fc (9 μg/ml). The presence of EphB3-Fc increased the amount of axon outgrowth from adult retinal explants. C, Growth cone extending on low laminin (2.5 μg/ml) and EphB3-Fc (9 μg/ml). D, Growth cone extending on L1 (0.25 μg/ml) and EphB3-Fc (10 μg/ml). E, Anti-tubulin staining in a growth cone similar to C. F, Phalloidin staining in the same growth cone as in E. G, Anti-GAP-43 immunostaining in a retinal axon grown on a laminin substratum (10 μg/ml). H, Immunostaining showing L1 protein expression on RGC axons within the optic nerve 12 d after injury. The asterisk indicates the injury site. I, Graph showing the dose–response relationship between the mean axon number with increasing concentrations of EphB3-Fc protein used for coating onto a laminin substratum. The numbers at the top of each column indicate the number of explants examined for the given experimental condition. J, Graph showing the relationship between total axon length (mean ± SEM) with increasing concentrations of EphB3-Fc protein used for substratum coating. The numbers at the top of each column indicate the number of explants examined for the given experimental condition. K, Graph showing the dose–response relationship between the percentage of retinal explants with axon outgrowth and increasing amounts of EphB3-Fc protein used for coating onto an L1 substratum. The numbers in parentheses represent the numbers of explants used in each condition. Data from five independent experiments (mean ± SEM) are shown. The percentage of retinal explants from EphrinB3 null animals with axon outgrowth on an L1/EphB3-Fc substratum is indicated by the open bar. Data from three independent experiments (mean ± SEM) are shown. L, Graph showing the dose–response relationship between the amount of outgrowth with increasing amounts of EphB3-Fc protein used for coating onto a, L1 substratum. The numbers in parentheses represent the total number of explants used in each condition. Data from three independent experiments (mean ± SEM) are shown. The amount of outgrowth from retinal explants of EphrinB3 null animals on an L1/EphB3-Fc substratum is indicated by the open bar. Data from three independent experiments (mean ± SEM) are shown. Scale bars: A, B, 50 μm; C, D, G, 5 μm; E, F, 2 μm; H, 100 μm. LN, Laminin.

Journal: The Journal of Neuroscience

Article Title: EphB3: An Endogenous Mediator of Adult Axonal Plasticity and Regrowth after CNS Injury

doi: 10.1523/JNEUROSCI.4797-05.2006

Figure Lengend Snippet: EphB3-Fc protein supports adult RGC axon outgrowth. A, Adult retinal explant grown on a substratum coated with low levels of laminin (2.5 μg/ml). This level of laminin coating supports only minimal axon outgrowth (arrow points to an axon). B, Adult retinal explant grown for 3 d on a substratum coated with low laminin (2.5 μg/ml) and EphB3-Fc (9 μg/ml). The presence of EphB3-Fc increased the amount of axon outgrowth from adult retinal explants. C, Growth cone extending on low laminin (2.5 μg/ml) and EphB3-Fc (9 μg/ml). D, Growth cone extending on L1 (0.25 μg/ml) and EphB3-Fc (10 μg/ml). E, Anti-tubulin staining in a growth cone similar to C. F, Phalloidin staining in the same growth cone as in E. G, Anti-GAP-43 immunostaining in a retinal axon grown on a laminin substratum (10 μg/ml). H, Immunostaining showing L1 protein expression on RGC axons within the optic nerve 12 d after injury. The asterisk indicates the injury site. I, Graph showing the dose–response relationship between the mean axon number with increasing concentrations of EphB3-Fc protein used for coating onto a laminin substratum. The numbers at the top of each column indicate the number of explants examined for the given experimental condition. J, Graph showing the relationship between total axon length (mean ± SEM) with increasing concentrations of EphB3-Fc protein used for substratum coating. The numbers at the top of each column indicate the number of explants examined for the given experimental condition. K, Graph showing the dose–response relationship between the percentage of retinal explants with axon outgrowth and increasing amounts of EphB3-Fc protein used for coating onto an L1 substratum. The numbers in parentheses represent the numbers of explants used in each condition. Data from five independent experiments (mean ± SEM) are shown. The percentage of retinal explants from EphrinB3 null animals with axon outgrowth on an L1/EphB3-Fc substratum is indicated by the open bar. Data from three independent experiments (mean ± SEM) are shown. L, Graph showing the dose–response relationship between the amount of outgrowth with increasing amounts of EphB3-Fc protein used for coating onto a, L1 substratum. The numbers in parentheses represent the total number of explants used in each condition. Data from three independent experiments (mean ± SEM) are shown. The amount of outgrowth from retinal explants of EphrinB3 null animals on an L1/EphB3-Fc substratum is indicated by the open bar. Data from three independent experiments (mean ± SEM) are shown. Scale bars: A, B, 50 μm; C, D, G, 5 μm; E, F, 2 μm; H, 100 μm. LN, Laminin.

Article Snippet: After transfer to nitrocellulose, blots were blocked with PBS/5% anti-donkey serum or dry milk and probed with anti-mouse EphB3 (1:1000; R & D Systems) or anti-human EphrinB3 (1:500; R & D Systems).

Techniques: Staining, Immunostaining, Expressing